DIVERSE PROGNOSIS IN METASTATIC BREAST-CANCER - WHO SHOULD BE OFFERED ALTERNATIVE INITIAL THERAPIES

被引：74

作者：

MICK, R

BEGG, CB

ANTMAN, KH

KORZUN, AH

FREI, E

机构：

[1] HARVARD UNIV,SCH MED,DANA FARBER CANC INST,DIV BIOSTAT,BOSTON,MA 02115

[2] HARVARD UNIV,SCH MED,DANA FARBER CANC INST,DIV MED,BOSTON,MA 02115

[3] HARVARD UNIV,SCH PUBL HLTH,BOSTON,MA 02115

来源：

关键词：

D O I：

10.1007/BF01806548

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：33 / 38

页数：6

共 23 条

[1] PROGNOSIS IN TETANUS - USE OF DATA FROM THERAPEUTIC TRIALS
ARMITAGE, P
CLIFFORD, R
[J]. JOURNAL OF INFECTIOUS DISEASES, 1978, 138 (01) : 1 - 8
[2] BITRAN JD, 1987, BREAST CANCER RES TR, V10, P88
[3] BUZDAR AU, 1981, CANCER, V47, P2798, DOI 10.1002/1097-0142(19810615)47:12<2798::AID-CNCR2820471207>3.0.CO
[4] 2-T
[5] CANELLOS GP, 1987, BREAST DISEASES, P385
[6] SURVIVAL FROM 1ST RECURRENCE - RELATIVE IMPORTANCE OF PROGNOSTIC FACTORS IN 1,015 BREAST-CANCER PATIENTS
CLARK, GM
SLEDGE, GW
OSBORNE, CK
MCGUIRE, WL
[J]. JOURNAL OF CLINICAL ONCOLOGY, 1987, 5 (01) : 55 - 61
[7] COOPER RG, 1969, P AM ASSOC CANC RES, V10, P15
[8] COX DR, 1972, J R STAT SOC B, V34, P187
[9] ADJUVANT CHEMOTHERAPY OF OSTEOGENIC-SARCOMA - PROGRESS AND PERSPECTIVES
FREI, E
JAFFE, N
GERO, M
SKIPPER, H
WATTS, H
[J]. JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1978, 60 (01): : 3 - 10
[10] DOSE - A CRITICAL FACTOR IN CANCER-CHEMOTHERAPY
FREI, E
CANELLOS, GP
[J]. AMERICAN JOURNAL OF MEDICINE, 1980, 69 (04) : 585 - 594